The European Union has sealed a deal to buy 900 million BioNTech-Pfizer Covid-19 vaccine doses with the option to add 900 million more, the European Commission has announced. In addition, the pharmaceutical companies are developing updated vaccines to combat resistant new variants of Covid-19, and future doses will be tailored to address this. Happy to announce that @EU_Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with @BioNTech_Group @Pfizer for 2021-2023. Under the EU agreement Ireland would secure approximately 4.9 million doses in 2022 and the same again in 2023. Ireland will also retain the option of securing an additional 9.8 million doses over the time period.

Source: The Irish Times May 08, 2021 10:31 UTC